Michael Petusky

Analyst

Barrington Research

Equibles does not estimate personal net worth.

About Michael Petusky

Michael Petusky is recorded as Analyst at Barrington Research. Michael Petusky has spoken on 4 earnings calls and 1 other investor event across 5 companies, most recently for Opko Health, Inc. on July 27, 2026. Those appearances were for Opko Health, Inc. (OPK), DENTSPLY SIRONA Inc. (XRAY), Haemonetics Corp (HAE), Lemaitre Vascular Inc (LMAT) and Option Care Health, Inc. (OPCH). The companies whose calls Michael Petusky spoke on are classified in the Healthcare sector.

Michael Petusky on recent calls

“I guess I wanted to ask, you know, on 4K score, You guys have expressed some hopes that, you know, things could open up there, you know, with primary care docs and, you know, maybe some payer policy advancements, et cetera, new opportunities.”

Analyst — Barrington Research, Q2 2026 Financial Results Conference Call · July 27, 2026

“Dan, I think it was in November on the third quarter conference call, you sort of called out some of the things you want to do in implants to sort of turn that business around.”

Analyst — Barrington Research, DENTSPLY SIRONA Inc. Q4 FY2025 Earnings Call · February 26, 2026

“Chris, so the guide for hospital for fiscal 26 seems to imply that you guys deliver the best quarter in hospital on a reported basis of the year.”

Analyst — Barrington Research, Haemonetics Corp Q3 FY2026 Earnings Call · February 5, 2026

“So, George, I guess I'm curious, with the stuff of the last, I guess, two months in the Middle East, are you guys seeing any impact from that, either just in terms of customers that you may have in that part of the world or just in general in terms of the cost of transporting things and so on and so forth?”

Analyst — Barrington Research, Piper Sandler 37th Annual Healthcare Conference · December 4, 2025